Poland· PL-100004822
Aminomel Nephro
A lösungen zur parenteralen ernährung, kombinationen product containing preparat złożony, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Baxter Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B05BA10
- ATC class
- Lösungen zur parenteralen Ernährung, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990261727
- gtin05909990261710
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lösungen zur parenteralen ernährung, kombinationen · interactions on record
6 records
- 2 severe
- 4 moderate
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B05BA10
Lösungen zur parenteralen ernährung, kombinationen, as other registers publish it.
- PolandAminomel 10 EBaxter Polska Sp. z o.o.
- PolandAminomel 12,5 EBaxter Polska Sp. z o.o.
- BelgiumAminomix 1 NovumFresenius Kabi
- CzechiaAMINOMIX 1 NOVUMFresenius Kabi Deutschland GmbH, Bad Homburg
- CzechiaAMINOMIX 1 NOVUMFresenius Kabi Deutschland GmbH, Bad Homburg
- CzechiaAMINOMIX 1 NOVUMFresenius Kabi Deutschland GmbH, Bad Homburg
- NetherlandsAminomix 1 Novum, oplossing voor infusieFresenius Kabi Nederland B.V.
- BelgiumAminomix 2 NovumFresenius Kabi
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c1624f2-5b32-4ae1-aae9-c5c8b6b77cf8 GET /v1/drugs/7c1624f2-5b32-4ae1-aae9-c5c8b6b77cf8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "-",
"packaging": "Lz ¦ Skasowane ¦ 739\n10 fl. 250 ml\nLz ¦ Skasowane ¦ 740\n10 fl. 500 ml\n05909990261727 ¦ Lz ¦ 13396\n1 butelka 500 ml\n05909990261710 ¦ Lz ¦ 48587\n1 butelka 250 ml",
"substance": "L-izoleucyna 6 g/1000 ml + L-Leucinum 6.4 g/1000 ml + L-Lysini acetas 10.27 g/1000 ml + L-metionina 4.59 g/1000 ml + L-fenyloalanina 5.53 g/1000 ml + L-treonina 5.13 g/1000 ml + L-Tryptophanum 2.05 g/1000 ml + L-walina 5.13 g/1000 ml + L-Argininum 30.2 g/1000 ml + L-Histydyna 3.88 g/1000 ml + L-Alanine 2.59 g/1000 ml + Acidum glutamicum 2.16 g/1000 ml + Glicyna 1.29 g/1000 ml + L-Prolinum 1.66 g/1000 ml + L-Serinum 2.59 g/1000 ml + Acetylcysteinum 0.54 g/1000 ml + N-acetylo-L-tyrozyna 0.37 g/1000 ml",
"common_name": "Preparat złożony",
"pl_product_id": "100004822",
"pozwolenie_nr": "02617",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about lösungen zur parenteralen ernährung, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.